When many people hear “coronary artery disease” (CAD), their first thought is often percutaneous coronary intervention—stents, wires, and catheters. But that reflexive association overlooks a broader, evidence-based reality: for many patients—especially those with stable CAD—intervention isn’t the only, or even the best, first-line strategy. Modern cardiovascular care emphasizes a layered, individualized approach where medications, lifestyle transformation, and advanced diagnostics work synergistically—not in isolation—to preserve heart function and reduce long-term risk.
Pharmacotherapy: A Tiered, Precision-Based Strategy
Medications for CAD are not interchangeable; they serve distinct, complementary roles. Anti-anginal agents—such as sublingual nitroglycerin—act within seconds to induce coronary vasodilation during acute episodes of chest discomfort, effectively relieving ischemia by reducing myocardial oxygen demand and improving blood flow. Long-term secondary prevention relies on foundational therapies including beta-blockers, ACE inhibitors or ARBs, and high-intensity statins—each targeting specific pathophysiological drivers like hypertension, tachycardia, endothelial dysfunction, and atherosclerotic plaque progression. Crucially, dual antiplatelet therapy (DAPT) or single antiplatelet regimens (e.g., aspirin or P2Y12 inhibitors) disrupt platelet aggregation pathways, significantly lowering the risk of thrombotic occlusion in vulnerable coronary segments. Adherence and regular clinical review are essential—these agents require careful titration and monitoring to balance efficacy with bleeding risk.
Lifestyle Medicine: The Cornerstone of Vascular Health
Robust clinical trial data consistently demonstrate that structured lifestyle modification rivals pharmacologic interventions in its impact on CAD progression and event reduction. The Mediterranean dietary pattern—rich in leafy greens, legumes, whole grains, fatty fish, nuts, and extra-virgin olive oil—has been shown in randomized trials (e.g., PREDIMED) to reduce major adverse cardiovascular events by over 30% compared with low-fat diets. Physical activity prescriptions should be personalized: moderate-intensity aerobic exercise (e.g., brisk walking, cycling, or swimming) for ≥150 minutes per week improves endothelial function, enhances collateral circulation, and lowers systemic inflammation. Equally vital is psychosocial support—chronic stress activates the sympathetic nervous system and hypothalamic-pituitary-adrenal axis, contributing to hypertension, insulin resistance, and plaque instability. Techniques such as mindfulness-based stress reduction, cognitive behavioral therapy, and structured relaxation training are now integrated into guideline-endorsed cardiac rehabilitation programs.
Advanced Diagnostics and Adjunctive Therapies
Contemporary imaging—including coronary computed tomography angiography (CCTA), stress echocardiography, and fractional flow reserve (FFR)–derived metrics—provides objective, quantitative assessment of stenosis severity, myocardial perfusion, and functional significance. These tools guide shared decision-making, helping clinicians distinguish between anatomically apparent lesions and those truly driving ischemia. For select patients with refractory angina despite optimal medical therapy, non-revascularization options include enhanced external counterpulsation (EECP), which augments diastolic coronary perfusion, or transmyocardial laser revascularization (TMR) in highly specialized centers. However, these remain adjunctive—not替代—strategies and require rigorous patient selection.
Ultimately, managing coronary artery disease is neither a binary choice nor a one-size-fits-all protocol. It is a dynamic, multidimensional process grounded in shared decision-making, continuous risk assessment, and coordinated care across cardiology, primary care, nutrition, and behavioral health disciplines. As guidelines from the American College of Cardiology and European Society of Cardiology increasingly emphasize, the most effective treatment plan is not defined by technological sophistication—but by its fidelity to the patient’s physiology, preferences, and lived experience.